(864) 370-3297 info@glytecsystems.com

About
Solutions
Resources
Case Studies
Blog
Request a Demo

Evidence

The safety and efficacy of Glytec’s solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences around the globe. We invite you to explore them here.

Filter by Topic

Hypoglycemia Reduction Inpatient Glycemic Management SubQ Insulin IV Insulin Length of Stay Reduction Diabetic Ketoacidosis (DKA) Resolution A1C Reduction Basal Bolus Adoption Cardiovascular Patients Cost of Care Reduction Hyperglycemia Reduction Staff Education Surgical Patients Academic Medical Center Connected Diabetes Technologies ICU Outpatient Glycemic Management Readmissions Reduction Research Study Virtual Care Clinical Surveillance POC Testing Time Savings Transition IV to SubQ Competitive Comparison Continuous Glucose Monitoring Emergency Department Glucommander™ H2H® (Hospital to Home) Heart Failure Patients Patients Without Diabetes

This is a search field with an auto-suggest feature attached.

There are no suggestions because the search field is empty.

Use of the eGlycemic Management Solution by Glytec Produces Less Hypoglycemia for Patients Managed on Subcutaneous Insulin Therapy

Read More

Practice Changes in Blood Glucose Management Following Open Heart Surgery: From a Prospective Randomized Study to Everyday Practice

Read More

Improvement in Inpatient Glycemic Care Pathways to Quality

Read More

Tides of Change Improving Glucometrics in a Large Multihospital Health Care System

Read More

Use of the eGlycemic Management System by Glytec Provides Safe and Effective Transition from IV to SubQ Insulin Therapy

Read More

Management of Hyperglycemia and Reduction in Hypoglycemia in Psychiatric Patients Using eGlycemic Management System

Read More

Comparative Effectiveness of a Computerized Algorithm Versus a Physician Instituted Protocol to Manage Insulin Infusions After Cardiac Surgery

Read More

Sentara Health System Sees Glycemic Improvement for Hospital Basal Bolus Patients in the First 30 Days Using eGlycemic Management System by Glytec

Read More

Sentara Health System Prepares for VBP Measure Changes With SCIP Inf-4 by Turning to Patient Centric IV Insulin Dosing Software

Read More

Mountain States Health Alliance Achieves Dramatic Improvements in Glycemic Control With The eGlycemic Management System By Glytec

Read More

Hospitalization Costs, Resource Utilization, and Clinical Outcome in Patients Undergoing CABG Receiving Intensive Versus Conservative Glucose Control

Read More

Patient Safety Initiative: Reducing Adverse Drug Events (ADE) With an Integrated Electronic Glycemic Management System (GMS)

Read More

Integration and Patient Care Success A Case Study Using an Integrated Glycemic Management System (GMS)

Read More

Glytec eGlycemic Management System in Combination With Clinical Surveillance Reduces Hypoglycemia and Can Identify Patients at Risk of Increased Length of Stay in Hospitalized Patients With Diabetic K

Read More

New Interfaces for eGlycemic Management System Save Nursing Time and Improve Patient Outcomes Time and Motion Nursing Study

Read More

Use of Computer-Based Insulin Delivery Method in Management Of Pediatric Diabetic Ketoacidosis (DKA) in a Pediatric Intensive Care Unit (PICU)

Read More

Effectively Identifying the Inpatient With Hyperglycemia to Increase Patient Care and Lower Costs

Read More

Inpatient Glycemic Control in 4 Easy Steps

Read More

Treatment of Diabetic Ketoacidosis in the Emergency Department Utilizing a Web Based Insulin Infusion Algorithm

Read More

A Computer Program, Directed by Clinicians for Outpatients, Which Re-adjusts Subcutaneous Multiple Daily Injections (MDI) of Insulin, Achieves an Improvement of 2.6 A1c% Points

Read More

Perioperative Use of the Glucommander for Glucose Control in Patients Undergoing Cardiac Surgery

Read More

Use of the Glucommander for Glycemic Control in Cardiac Surgery Patients

Read More

A Comparison Study of Continuous Insulin Infusion Protocols in the Medical Intensive Care Unit Computer-Guided Vs. Standard Column-Based Algorithms

Read More

A Computerized Intravenous Insulin Controller (CIIC) Shows Significantly Less Hypoglycemia Than NICE-SUGAR and Eight Paper Protocols for Intensive Control - 0.3% vs. 12.6%

Read More

Evaluating the Safety and Efficacy of Glucommander, a Computer-based Insulin Infusion Method, in Management of Diabetic Ketoacidosis in Children

Read More

Use of a Computerized Intravenous Insulin Algorithm Within a Nurse-Directed Protocol for Patients Undergoing Cardiovascular Surgery

Read More

Use of a Computerized Algorithm in Patients Undergoing Cardiovascular Surgery: A Protocol for Tight Glycemic Control

Read More

Financial Implications of Glycemic Control: Results of an Inpatient Diabetes Management Program

Read More

Prev 1 2 3 Next

Subscribe to our blog

Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.

Terms of Use
Legal Disclaimer
Privacy Policy
Contraindications, Warnings and Precautions

© 2023 Glytec, LLC on behalf of Aseko, Inc.

The eGlycemic Management System^® is a modularized solution for glycemic management across the care continuum that includes Glucommander^™. Glucommander^™ is a prescription-only software medical device for glycemic management intended to evaluate current as well as cumulative patient blood glucose values coupled with patient information including age, weight and height, and, based on the aggregate of these measurement parameters, whether one or many, recommend an IV dosage of insulin, glucose or saline or a subcutaneous basal and bolus insulin dosing recommendation to adjust and maintain the blood glucose level towards a configurable physician- determined target range. Glucommander^™ is indicated for use in adult and pediatric (ages 2-17 years) patients. The measurements and calculations generated are intended to be used by qualified and trained medical personnel in evaluating patient conditions in conjunction with clinical history, symptoms, and other diagnostic measurements, as well as the medical professional’s clinical judgement. No medical decision should be based solely on the recommended guidance provided by this software program.

Glucommander^™ is only available for use in the United States.

This site is only intended for use in the United States.

Aseko is a registered trademark of Aseko, Inc.